We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Pfizer Inc. and BioNTech SE’s Covid-19 vaccine won the backing of a key European review panel, clearing the way for inoculations to start before year-end.